PHENOTYPIC CORRECTION OF FANCONI-ANEMIA IN HUMAN HEMATOPOIETIC-CELLS WITH A RECOMBINANT ADENOASSOCIATED VIRUS VECTOR

被引:137
作者
WALSH, CE
NIENHUIS, AW
SAMULSKI, RJ
BROWN, MG
MILLER, JL
YOUNG, NS
LIU, JM
机构
[1] ST JUDE CHILDRENS RES HOSP, MEMPHIS, TN 38112 USA
[2] UNIV N CAROLINA, DEPT PHARMACOL, CHAPEL HILL, NC 27599 USA
[3] OREGON HLTH SCI UNIV, PORTLAND, OR 97201 USA
关键词
GENE THERAPY; TRANSDUCTION; DNA REPAIR; HEMATOPOIESIS;
D O I
10.1172/JCI117481
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Fanconi anemia (FA) is a recessive inherited disease characterized by defective DNA repair. FA cells are hypersensitive to DNA cross-linking agents that cause chromosomal instability and cell death. FA is manifested clinically by progressive pancytopenia, variable physical anomalies, and predisposition to malignancy. Four complementation groups have been identified, termed A, B, C, and D. The gene for the FA complementation group C, FACC, has been cloned. Expression of the FACC cDNA corrects the phenotypic defect of FA(C) cells, resulting in normalized cell growth in the presence of DNA cross-linking agents such as mitomycin C (MMC). Gene transfer of the FACC gene should provide a survival advantage to transduced hematopoietic cells, suggesting that FA might be an ideal candidate for gene therapy. We demonstrated efficient transduction, expression, and phenotypic correction in lymphoblastoid cell lines derived from FA(C) patients using a recombinant adeno-associated virus (rAAV) vector containing the FACC gene. Molecular characterization of the transduced FACC gene showed an intact unrearranged proviral genome with expression sufficient to normalize cell growth, cell cycle kinetics and chromosomal breakage in the presence of MMC. These observations were extended by testing rAAV transduction in hematopoietic progenitor cells. Peripheral blood CD34(+) cells isolated from a FA(C) patient and transduced with rAAV/FACC virus yielded 5-10-fold more progenitor colonies than mock-infected cells, consistent with genetic ''rescue'' of corrected cells. This is the first demonstration of rAAV gene correction in primary human hematopoietic progenitor cells and has important implications for gene therapy of hematopoietic disorders, specifically FA.
引用
收藏
页码:1440 / 1448
页数:9
相关论文
共 47 条
[1]  
ALTER BP, 1992, BLOOD, V80, P3000
[2]  
ALTER BP, 1993, HEMATOLOGY INFANCY C, P216
[3]   HUMAN HEMATOPOIETIC PRECURSORS IN LONG-TERM CULTURE - SINGLE CD34+ CELLS THAT LACK DETECTABLE T-CELL, B-CELL, AND MYELOID CELL ANTIGENS PRODUCE MULTIPLE COLONY-FORMING CELLS WHEN CULTURED WITH MARROW STROMAL CELLS [J].
ANDREWS, RG ;
SINGER, JW ;
BERNSTEIN, ID .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (01) :355-358
[4]  
AUERBACH AD, 1989, BLOOD, V73, P391
[5]  
BAGBY GC, 1993, EXP HEMATOL, V21, P1419
[6]   FANCONI-ANEMIA - CHROMOSOME BREAKAGE AND CELL-CYCLE STUDIES [J].
BERGER, R ;
LECONIAT, M ;
GENDRON, MC .
CANCER GENETICS AND CYTOGENETICS, 1993, 69 (01) :13-16
[7]   DUAL-TARGET INHIBITION OF HIV-1 INVITRO BY MEANS OF AN ADENOASSOCIATED VIRUS ANTISENSE VECTOR [J].
CHATTERJEE, S ;
JOHNSON, PR ;
WONG, KK .
SCIENCE, 1992, 258 (5087) :1485-1488
[8]   THE CELL-CYCLE OF LYMPHOCYTES IN FANCONI ANEMIA [J].
DUTRILLAUX, B ;
AURIAS, A ;
DUTRILLAUX, AM ;
BURIOT, D ;
PRIEUR, M .
HUMAN GENETICS, 1982, 62 (04) :327-332
[9]   RESPONSE OF FANCONI ANEMIA FIBROBLASTS TO ADENINE AND PURINE ANALOGS [J].
FRAZELLE, JH ;
HARRIS, JS ;
SWIFT, M .
MUTATION RESEARCH, 1981, 80 (02) :373-380
[10]   A LEU(554)-TO-PRO SUBSTITUTION COMPLETELY ABOLISHES THE FUNCTIONAL COMPLEMENTING ACTIVITY OF THE FANCONI ANEMIA (FACC) PROTEIN [J].
GAVISH, H ;
DOSSANTOS, CC ;
BUCHWALD, M .
HUMAN MOLECULAR GENETICS, 1993, 2 (02) :123-126